| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 06/19/2008 | US20080146740 Process for the controlled increase in the molecular weight of polyethylenes |
| 06/19/2008 | US20080146556 Poly (ADP-ribose) polymerase 1 inhibitors as radio-sensitization agents of tumors; 7-methoxy-1,2,3,11-tetrahydro-5,11-diaza-benzo[a]trindene-4,6-dione |
| 06/19/2008 | US20080146546 Bicyclic and Tricyclic Heteroaromatic Compounds |
| 06/19/2008 | US20080146542 Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, Process for Preparing Them, Compositions Containing Them and Use Thereof |
| 06/19/2008 | US20080146539 New carboxylic acid amides, the preparation thereof and their use as medicaments |
| 06/19/2008 | US20080146537 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 06/19/2008 | US20080145335 Which protect neural cells from degeneration and/or death in response to injury or disease; hypoxia/ischemia, toxic injury, and chronic neurodegenerative disorders including Parkinson's disease |
| 06/19/2008 | CA2672591A1 Treating agent of uropathy |
| 06/19/2008 | CA2672295A1 Aspartyl protease inhibitors containing a tricyclic ring system |
| 06/19/2008 | CA2671980A1 Quinoxaline derivatives |
| 06/18/2008 | EP1932846A1 Method for producing sulfonyl chloride compound |
| 06/18/2008 | EP1931735A1 High-purity texaphyrin metal complexes |
| 06/18/2008 | EP1931677A2 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 06/18/2008 | EP1931676A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 06/18/2008 | EP1931675A2 Pyrazolo(1, 5a) pyrimidines as protein kinase inhibitors |
| 06/18/2008 | EP1931674A2 Deazapurines useful as inhibitors of janus kinases |
| 06/18/2008 | EP1931673A1 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging |
| 06/18/2008 | EP1931672A1 Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease. |
| 06/18/2008 | EP1931671A1 Alkyl 4- [4- (5-oxo-2, 3, 5, 11a-tetrahyd0-5h-pyrr0l0 [2, 1-c][1, 4]benzodiazepine-8-yloxy) -butyrylamino]-1h-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative disease |
| 06/18/2008 | EP1931641A2 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI |
| 06/18/2008 | EP1846401B1 New 4-aminoquinoline derivatives as antimalarials |
| 06/18/2008 | EP1802625B1 Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer |
| 06/18/2008 | EP1697376B1 Spiro-condensed indoline derivatives as pesticides |
| 06/18/2008 | EP1684763B1 6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agent |
| 06/18/2008 | CN101203522A Antineoplastic compounds and pharmaceutical compositions thereof |
| 06/18/2008 | CN101203516A Purine and imidazopyridine derivatives for immunosuppression |
| 06/18/2008 | CN101203495A Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
| 06/18/2008 | CN101200469A Separation of regioisomers of metal phthalocyanines |
| 06/18/2008 | CN101200468A Novel compounds and uses thereof |
| 06/18/2008 | CN100395246C Method for producing folic acid antagonist and its intermediate |
| 06/17/2008 | US7388099 Hydroxycucurbituril derivatives, their preparation methods and uses |
| 06/17/2008 | US7388027 sarcopenia,frailty or age-related functional decline; nonsteroidal, nontoxic; side effect reduction;2-Chloro-4-(7-hydroxy-1-methyl-3-oxo-5,6,7,7a-tetrahydro-3H-pyrrolizin-2-yl)-3-methylbenzonitrile |
| 06/17/2008 | US7388024 Indeno[2,1A]indenes and isoindolo[2,1-A]indoles |
| 06/17/2008 | US7388019 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/17/2008 | US7388014 Quinazoline derivatives and therapeutic use thereof |
| 06/17/2008 | US7388010 fused hexacyclic derivatives consist of pyrrolidine, indazolone, quuinoxalinone rings; cyclin-dependent kinase inhibitor with cell growth-inhibitory activity; anticarcinogenic and antiproliferative agent |
| 06/17/2008 | US7388009 Heterocyclic drugs as enzyme inhibitors for Kinase enzymes or prodrugs |
| 06/17/2008 | US7388005 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-a]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 06/17/2008 | CA2501799C Pyrazole compounds for treatment of neurodegenerative disorders |
| 06/17/2008 | CA2451990C A new compound for the treatment of impotence |
| 06/17/2008 | CA2367704C Pyrazolobenzodiazepines as cdk2 inhibitors |
| 06/17/2008 | CA2249446C Irreversible inhibitors of tyrosine kinases |
| 06/17/2008 | CA2202487C Fused pyrrolocarbazoles |
| 06/12/2008 | WO2008070661A1 Substituted pyrimidines as adenosine receptor antagonists |
| 06/12/2008 | WO2008070507A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/12/2008 | WO2008070313A2 3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use |
| 06/12/2008 | WO2008069997A1 Substituted diazepan compounds as orexin receptor antagonists |
| 06/12/2008 | WO2008069500A1 Triazolopyridazine derivatives having inhibitory activity against acetyl-coa carboxylase |
| 06/12/2008 | WO2008068600A2 An improved process for the preparation of zaleplo |
| 06/12/2008 | WO2008068424A2 Substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 06/12/2008 | WO2008068272A2 Antibacterial quinoline derivatives |
| 06/12/2008 | WO2008068171A1 Substituted pyrimidines and their use as jnk modulators |
| 06/12/2008 | WO2008067965A1 3,4 diaminopyridine derivatives |
| 06/12/2008 | WO2008047210A3 Compounds derived from 1 -ethyl-4,5-diamino-pyrazole and their use for oxidative dyeing of keratin fibres |
| 06/12/2008 | WO2008046581A3 Substituted tetrahydropyrrolopyrazine compounds and use thereof in medicaments |
| 06/12/2008 | US20080139821 Disubstituted Cucurbiturils and Preparing Method Thereof |
| 06/12/2008 | US20080139810 Combining pemetrexed diacid, an agent capable of forming a salt of pemetrexed, water and a solvent; removing the solvent by lyophilization |
| 06/12/2008 | US20080139805 Process for producing carbapenem derivative having a 1-alkylpyrrolidine structure |
| 06/12/2008 | US20080139804 Photosensitive Compounds |
| 06/12/2008 | US20080139786 Exposing azo, azide and sulfenate agents to visible or infrared light; use in medical procedures to cause necrosis or apoptosis of tissue |
| 06/12/2008 | US20080139622 Decahydronaphthalene Compounds |
| 06/12/2008 | US20080139601 3-Cyano-Quinoline Derivatives With Antiproliferative Activity |
| 06/12/2008 | US20080139595 Hetaryloxy-Substituted Phenylamino Pyrimidines as Rho Kinase Inhibitors |
| 06/12/2008 | US20080139588 Pyrrolo[2,3-d]pyrimidine cytokine inhibitors |
| 06/12/2008 | US20080139582 Inhibitors of bruton's tyrosine kinase |
| 06/12/2008 | US20080139581 2-Substituted 7-Aminoazolopyrimidines, Processes For Their Preparation And Their Use For Controlling Harmful Fungi, And Compositions Comprising These Compounds |
| 06/12/2008 | US20080139580 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
| 06/12/2008 | US20080139571 Imidazopyrazines as protein kinase inhibitors |
| 06/12/2008 | US20080139569 Novel crystalline form |
| 06/12/2008 | US20080139567 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome |
| 06/12/2008 | US20080139524 Pharmaceutical formulation comprising a metaloporphyrin and method for its purification and use |
| 06/12/2008 | US20080139461 Containing the sequence RGD for the preparation of appropriately functionalised antagonists of alpha v beta 3 and alpha v beta 5 integrins; treatment of altered angiogenic phenomena or for the preparation of diagnostically useful compounds |
| 06/12/2008 | US20080138817 Novel Functional Peptide Nucleic Acid Monomer and Process for Producing the Same |
| 06/12/2008 | US20080138287 3-substituted-2(arylalkyl)-1- azabicycloalkanes and methods of use thereof |
| 06/12/2008 | CA2671990A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/12/2008 | CA2670892A1 Substituted diazepan compounds as orexin receptor antagonists |
| 06/12/2008 | CA2670375A1 Substituted pyrimidines and their use as jnk modulators |
| 06/12/2008 | CA2668558A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2668196A1 Substituted 2,5-dfflydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 06/12/2008 | CA2664940A1 3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use |
| 06/11/2008 | EP1930335A1 Cephalosporines having cyclic aminoguanidine substituents as Antibiotics |
| 06/11/2008 | EP1930332A1 Luminescent vargula luciferin substrate and process for producing the same |
| 06/11/2008 | EP1930331A1 METHOD FOR PRODUCING IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 06/11/2008 | EP1930330A1 Pleuromutilin derivatives as antimicrobials |
| 06/11/2008 | EP1930319A1 Proline derivatives and use thereof as drugs |
| 06/11/2008 | EP1928886A1 Pyridine derivatives and their use in the treatment of psychotic disorders |
| 06/11/2008 | EP1928880A1 Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester |
| 06/11/2008 | EP1928879A2 Fused heterocyclic compounds useful as kinase modulators |
| 06/11/2008 | EP1928878A1 Methods for the preparation of hcv polymerase inhibitors |
| 06/11/2008 | EP1928874A1 Heterobicyclic compounds as glucokinase activators |
| 06/11/2008 | EP1928843A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseaes |
| 06/11/2008 | EP1928467A2 N-benzyl substituted pyridyl porphyrin compounds and methods of use thereof |
| 06/11/2008 | EP1928461A1 Pyrimidine compounds as serotonin receptor modulators |
| 06/11/2008 | EP1633754B1 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors |
| 06/11/2008 | EP1497266B1 Quinoline derivatives and their use as 5-ht6 ligands |
| 06/11/2008 | EP1444235B1 Reverse-turn mimetics and method relating thereto |
| 06/11/2008 | EP1255739B1 3-aminoquinazolin-2,4-dione antibacterial agents |
| 06/11/2008 | CN101198611A Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use |
| 06/11/2008 | CN101198610A Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-n-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein |
| 06/11/2008 | CN101198609A Aspartyl protease inhibitors |